GPAT in upward trend: 10-day moving average moved above 50-day moving average on October 01, 2026
The 10-day moving average for GPAT crossed bullishly above the 50-day moving average on October 01, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 1 of 4 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 25%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 2 of 22 cases where GPAT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 9%.
The Momentum Indicator moved above the 0 level on October 01, 2026. You may want to consider a long position or call options on GPAT as a result. In 4 of 45 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 9%.
The Moving Average Convergence Divergence (MACD) for GPAT just turned positive on October 05, 2026. Looking at past instances where GPAT's MACD turned positive, the stock continued to rise in 2 of 36 cases over the following month. The odds of a continued upward trend are 6%.
GPAT moved above its 50-day moving average on October 05, 2026 date and that indicates a change from a downward trend to an upward trend.
Bearish Trend Analysis
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 52 (best 1 - 100 worst), indicating steady price growth. GPAT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.173) is normal, around the industry mean (132.155). P/E Ratio (44.000) is within average values for comparable stocks, (171.505). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (15.932). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. GPAT's P/S Ratio (0.000) is very low in comparison to the industry average of (3.158).
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GPAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock worse than average.